227 related articles for article (PubMed ID: 22954143)
1. Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging.
Korkusuz H; Ulbrich K; Bihrer V; Welzel K; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Korkusuz Y; Kromen W; Hammerstingl R; Haupenthal J; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging; 2012; 11(4):272-9. PubMed ID: 22954143
[TBL] [Abstract][Full Text] [Related]
2. Transferrin-coated gadolinium nanoparticles as MRI contrast agent.
Korkusuz H; Ulbrich K; Welzel K; Koeberle V; Watcharin W; Bahr U; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Kromen W; Hammerstingl R; Haupenthal J; Gruenwald F; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging Biol; 2013 Apr; 15(2):148-54. PubMed ID: 22811020
[TBL] [Abstract][Full Text] [Related]
3. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Huebner F; Zeuzem S; Korf HW; Vogl TJ; Rittmeyer C; Terfort A; Piiper A; Gelperina S; Kreuter J
Eur J Pharm Biopharm; 2014 May; 87(1):132-41. PubMed ID: 24365328
[TBL] [Abstract][Full Text] [Related]
5. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
7. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents.
Giesel FL; von Tengg-Kobligk H; Wilkinson ID; Siegler P; von der Lieth CW; Frank M; Lodemann KP; Essig M
Invest Radiol; 2006 Mar; 41(3):222-8. PubMed ID: 16481904
[TBL] [Abstract][Full Text] [Related]
8. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
Zhen M; Zheng J; Ye L; Li S; Jin C; Li K; Qiu D; Han H; Shu C; Yang Y; Wang C
ACS Appl Mater Interfaces; 2012 Jul; 4(7):3724-9. PubMed ID: 22704586
[TBL] [Abstract][Full Text] [Related]
9. MR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.
Nakajima T; Turkbey B; Sano K; Sato K; Bernardo M; Hoyt RF; Choyke PL; Kobayashi H
J Magn Reson Imaging; 2014 Sep; 40(3):691-7. PubMed ID: 24123370
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of Gd-DTPA and HSA-Gd-DTPA in magnetic resonance lymphography].
Wu YK; Fang TS; Chen DC; Liu GQ; Xu YK
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct; 27(10):1597-600. PubMed ID: 17959548
[TBL] [Abstract][Full Text] [Related]
12. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
13. Functional Hyperbranched Polylysine as Potential Contrast Agent Probes for Magnetic Resonance Imaging.
Zu G; Liu M; Zhang K; Hong S; Dong J; Cao Y; Jiang B; Luo L; Pei R
Biomacromolecules; 2016 Jun; 17(6):2302-8. PubMed ID: 27187578
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.
Ahmed A; Zhang C; Guo J; Hu Y; Jiang X
Macromol Biosci; 2015 Aug; 15(8):1105-14. PubMed ID: 25846258
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
[TBL] [Abstract][Full Text] [Related]
17. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
[TBL] [Abstract][Full Text] [Related]
18. Investigation of non-covalent interactions between paramagnetic complexes and human serum albumin by electrospray mass spectrometry.
Henrotte V; Laurent S; Gabelica V; Elst LV; Depauw E; Muller RN
Rapid Commun Mass Spectrom; 2004; 18(17):1919-24. PubMed ID: 15329857
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]